Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This is a cluster randomised controlled trial comparing the impact of two community based
malaria interventions: reactive case detection (RACD) vs reactive targeted presumptive
treatment (focal mass drug administration, fMDA) on the incidence of malaria in Swaziland.
Phase:
Phase 3
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Clinton Health Access Initiative, Eswatini Clinton Health Access Initiative, Nigeria Ministry of Health, Swaziland University of Texas